The University at Buffalo's Research Institute on Addictions (RIA) will host national experts on addictions and substance abuse during a fall seminar series that will begin Sept. 29.
The inaugural issues of a new Institute Policy Brief series, prepared by the University at Buffalo Institute for Local Governance and Regional Growth, contain key findings on two important regional issues -- youth demographics and the binational economy.
Music is Art LIVE @ The Center, a television series of the Center for the Arts at the University at Buffalo, has been chosen as a recipient of a Bronze Telly Award for Lighting Design.
The topic of the Aug. 10 lecture in the UBThisSummer Lecture Series presented by the University at Buffalo has been changed due to the death of scheduled lecturer Paul Senese, associate professor of political science. The new lecture for that date is entitled "From Caring to Care-Giving: How Families Cope with Chronic Illness" and will be presented by Deborah P. Waldrop, associate professor in the UB School of Social Work.
"Human Trials" is a unique virtual reality psychodrama in which duplicitous characters try to disempower a human participant on a journey to the "liminal portal of the unconscious" in a quest for her "Heart's Desire." The project is the work of an interdisciplinary team of media artists, computer scientists and dramatists at the University at Buffalo.
A study conducted by researchers at the University at Buffalo's Research Institute on Addictions has found cocaine-using mothers to be more insensitive during feeding interactions with their infants than non-cocaine-using mothers.
The number 666 -- the "number of the beast," according to the Book of Revelation -- conjures devilish images for many, so forecasts of evil, even doom, are rampant regarding dates or places where the number occurs, including next Tuesday, June 6, or 6-6-06.
William E. Pelham, Jr., Ph.D., professor of psychology, pediatrics and psychiatry at the University at Buffalo and one of the leading experts in the treatment of attention deficit hyperactivity disorder (ADHD) in children, has received a total of $5.8 million to begin two new studies of treatment approaches for the condition.